New HPV vaccine could be even more effective at protecting against cervical cancer

New HPV vaccine could be even more effective at protecting against cervical cancer
(Image credit: iStock)

A new vaccine against human papillomavirus (HPV), which can cause cervical cancer, could be even more effective, according to research published in the journal Cancer Epidemology, Biomarkers, and Prevention.

The new vaccine, developed by drug maker Merck, will protect against nine strains of HPV and could be 90 percent effective. The current vaccine, GARDASIL, protects against four strains and is 70 percent effective.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More